الفهرس 
Aim of the WorkOnly 14 pages are availabe for public view
 |  | from | 103 |  |  |
| | | from | 103 | | |
Abstract
Uterine cervical cancer is one of the most common malignancies affecting the female in middle age group all over the world.
MRI, although not officially incorporated in the FIGO staging system, is already widely accepted as the most reliable imaging technique for the diagnosis, staging, treatment planning, and follow-up of both endometrial and cervical cancer.
The aim of this study was to evaluate the role of MRI in cancer cervix diagnosis and staging.
We examined 2 groups of patients. The case group consisted of 32 patients in whom cervical cancer had been suspected clinically or by Trans vaginal U/S and confirmed by biopsy .The control group consisted of 30 patients who had normal uterine cervix and MRI was performed because of other Pelvic diseases.
Pelvic MR with DWI were done for all patients, DCE- MR was done for almost all patients.
The locations of the 32 cervical lesions in MR images included 9 (28.1%) in the posterior wall, 2 (6.2%) in left lateral wall, 5 (15.6%) in right lateral wall, 14 (43.8%) seen circumferentially, and 2 (6.2%) in anterior wall. The size of the detected masses ranged from 2.4 to 11 cm (mean= 6.05±2.23).
Hypointense T1 signal was seen in 12 patients (37.5%) while isointense T1 signal was recorded in 20 patients (62.5%). Hyper-intense T2 signal was seen in 24 patients (75%) while isointense T2 signal was recorded in 8 patients (25%).
T1WI with contrast was performed to 31 patients, 20 masses showed heterogenous enhancement, 9 masses showed homogenous enhancement while 2 masses showed no enhancement.
According to FIGO staging system in correlation with MRI findings, 4 patients were stage IB (12.9%), 3 lesions were stage IIA (9.7%), 10 lesions were stage IIB (32.2%), 5 lesions were stage IIIB (16.1%), 7 lesions were stage IVA (22.6%), and 2 cases were stage IVB (6.5%).